Research indicates that luminal A breast cancers are relatively less aggressive, while luminal B breast cancers exhibit greater aggressiveness; HER2-positive breast cancers demonstrate a moderate level of aggressiveness, whereas TNBC is identified as the most aggressive subtype [24]. This evidence concerns the gene ERBB2 and breast cancer.